Global Tumour Ablation Market 2017 Worth USD 3.5 Billion, at a CAGR of 8.2% by 2024

Latest research on “Global Tumour Ablation Market has accounted for USD 1.8 billion in 2016, expected to reach USD 3.5 billion by 2024, growing at a CAGR of 8.2% in the forecast period 2017 to 2024”, also the Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024

This report consists of below pages:

• No of pages: 350
• No of Figures: 60
• No of Tables: 220

Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-tumour-ablation-market

Report Definition:

The global tumour ablation market is expected to grow, owing to factors such as rising cancer incidence, increased focus on treatment of breast cancer, better reimbursement scenarios, shift towards value based reimbursements and continuous development in ablation technology. The ablation technology has an upper edge on chemotherapy and other oncology therapeutics. However ablation technology can only be used to treat tumours with size less than 3cm, owing to the healthy tissue damage caused by it. With the advent of guidance mechanisms such as ultrasounds and MRI the accuracy of the treatment has increased significantly in the past 5 years.

Report Segmentation:

The global tumour ablation market is segmented based on product types, cancer types, end-user and geography.

The global tumour ablation market is segmented into 3 type’s ablation systems, image guidance products and accessories. The ablation systems dominates the market and is further segmented based on product type into microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled, catheter manipulation systems), high intensity focused ultrasound (HIFU), laser ablation and cryoablation.

On the basis of cancer types treated using ablation devices the market is segmented into liver, lings, kidney, brain, bone, pancreas, breast and, other cancer types.

Based on end-user the global tumour ablation market is segmented into hospitals, oncology clinics and others.

For Any Query Speak to Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-tumour-ablation-market

Geographical Segmentation:

Based on geography the global tumour ablation market is segmented into 5 geographical regions:

• North America
• Europe
• Asia-Pacific
• South America
• Rest of the World

The geographical regions are further segmented into 24 major countries such as U.S., Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2016, Europe is expected to dominate the market with 36.7% market share, owing to the large incidence of cancer patients in this region coupled with good reimbursements.

Competitive Landscape:

The tumour ablation market report major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some examples of recent strategies/developments are: On January, 2016 Medtronic acquired OsteoCool RF Ablation System from Baylis Medical and received its FDA approval, December, 2015 DFINE, Inc. launched Long SpineStar ablation system, January 2015, Medtronic acquired Covidien to strengthen its leadership in medical devices industry among others. The report includes market shares of tumor ablation market for global, Europe, North America, Asia Pacific and Rest of the World. In 2015, Medtronic has dominated the global tumour ablation market.

Some of the other key players operating in this market are Galil Medical, Inc., Perseon Corporation, NeuWave Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc., Misonix, Inc., BVM Medical Limited, AngioDynamics, Inc., COMSOL Inc., Boston Scientific Corporation, EDAP TMS S.A. and, HealthTronics, Inc. among other companies.

Read more news about this Report Visit @ http://databridgemarketresearch.com/reports/global-tumour-ablation-market/

Table of Contents:

1. INTRODUCTION
1.1. OVERVIEW OF THE TUMOUR ABLATION MARKET
1.2. MARKET SEGMENTATION & COVERAGE
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE TUMOUR ABLATION MARKET SIZE
2.3. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. MARKET OVERVIEW
4.1. OVERVIEW
4.2. TUMOUR ABLATION MARKET: KEY PRIMARY INSIGHTS
4.3. DRIVERS, OPPORTUNITIES AND THREAT ANALYSIS MATRIX
4.4. KEY MARKET FINDINGS
4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. TUMOUR ABLATION MARKET, BY TYPE
5.1. OVERVIEW
5.2. TUMOUR ABLATION SYSTEMS
5.2.1. RADIO FREQUENCY ABLATION SYSTEM (RFA)
5.2.2. MICROWAVE ABLATION SYSTEM
5.2.3. HIGH FREQUENCY FOCUSED ULTRASOUND ABLATION SYSTEM (HIFU)
5.2.4. LASER ABLATION SYSTEM
5.2.5. CRYOABLATION
5.3. IMAGE GUIDANCE PRODUCTS
5.4. ACCESSORIES
6. TUMOUR ABLATION MARKET, BY CANCER TYPE
7. TUMOR ABLATION MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. ONCOLOGY CLINICS
7.4. OTHERS
8. TUMOUR ABLATION MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE TUMOUR ABLATION MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
9. TUMOUR ABLATION MARKET: COMPETITIVE LANDSCAPE
9.1. GLOBAL TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
9.2. NORTH AMERICA TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
9.4. APAC TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
9.5. MERGERS & ACQUISITIONS
9.6. NEW PRODUCT DEVELOPMENT & APPROVALS
9.7. EXPANSIONS
9.8. REGULATORY CHANGES
9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10. TUMOUR ABLATION MARKET, COMPANY PROFILES
10.1. MEDTRONIC
10.2. GALIL MEDICAL, INC.
10.3 PERSEON CORPORATION
10.4 NEUWAVE MEDICAL, INC.
10.5. KONINKLIJKE PHILIPS N.V.
10.6. INTIO INC.
10.7. MERMAID MEDICAL A/S
10.8. SONACARE MEDICAL, LLC
10.9. DFINE, INC.
10.10. MISONIX, INC.
10.11. BVM MEDICAL LIMITED
10.12. ANGIODYNAMICS, INC.
10.13. COMSOL INC.
10.14. BOSTON SCIENTIFIC CORPORATION
10.15. EDAP TMS S.A.
10.16. HEALTHTRONICS, INC.
11. APPENDIX
12. ABOUT DATA BRIDGE MARKET RESEARCH

Related Report

Global Ablation Devices Market – Trends and Forecast to 2024

Global Ablation Devices Market, By Technology (Electrical, Radiation, Radiofrequency, Light, Ultrasound, Cryotherapy, Thermal, Microwave, Hydro-mechanical), By Application (Cancer, Cardiovascular, Orthopedics, Urology, Gynecology, Ophthalmology and Others), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-ablation-devices/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.